HIGHLIGHTS
- who: Surface-Catalyzed Secondary and colleagues from the Department of Biochemistry and Structural Biology, Lund University, Lund, Sweden, Wren Therapeutics Limited, Clarendon Cambridge, Cambridge, United Kingdom, Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom have published the Article: Surface-Catalyzed Secondary Nucleation Dominates the Generation of Toxic IAPP Aggregates, in the Journal: (JOURNAL)
- what: For diabetes type II, and indicates that the design of inhibitors of secondary nucleation could be developed as a treatment to preserve or restore the function of β-cells in this disease.
SUMMARY
Approximately 4.2 million deaths . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.